Cite
HARVARD Citation
Fuoco, V. et al. (2022). Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects. Tumori. 108 (4), pp. 315-325. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fuoco, V. et al. (2022). Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects. Tumori. 108 (4), pp. 315-325. [Online].